Christopher Salerno to Aged
This is a "connection" page, showing publications Christopher Salerno has written about Aged.
Connection Strength
0.405
-
Opening the "Dor," Not Always an Inferior Approach. ASAIO J. 2019 07; 65(5):e50-e51.
Score: 0.053
-
Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis. JACC Heart Fail. 2017 10; 5(10):691-699.
Score: 0.047
-
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
Score: 0.036
-
[Comparison of the leukaemia incidence in two cohorts of farmers and traders in the Vercelli province of Italy, 2002-2009]. Ann Ig. 2011 Jan-Feb; 23(1):27-32.
Score: 0.029
-
Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation? Eur J Cardiothorac Surg. 2007 Mar; 31(3):457-61.
Score: 0.022
-
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
Score: 0.017
-
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
Score: 0.014
-
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
Score: 0.013
-
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
Score: 0.013
-
Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J. 2018 Nov/Dec; 64(6):715-720.
Score: 0.013
-
Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J. 2018 Nov/Dec; 64(6):721-726.
Score: 0.013
-
Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
Score: 0.013
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
Score: 0.013
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
Score: 0.012
-
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 01; 37(1):7-14.
Score: 0.012
-
Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
Score: 0.012
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
Score: 0.011
-
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
Score: 0.011
-
Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
Score: 0.011
-
The HeartMate II Risk Score: An Adjusted Score for Evaluation of All Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2016 May-Jun; 62(3):281-5.
Score: 0.011
-
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
Score: 0.010
-
Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device. J Card Surg. 2015 Oct; 30(10):775-80.
Score: 0.010
-
Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
Score: 0.009
-
Coronary sinus injury during retrograde cardioplegia: a report of three cases. J Card Surg. 1996 Sep-Oct; 11(5):359-62.
Score: 0.003